Benzinga - by Avi Kapoor, Benzinga Staff Writer.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Morgan Stanley boosted Regency Centers Corporation (NASDAQ: REG) price target from $62 to $75. Morgan Stanley analyst Ronald Kamdem upgraded the stock from Equal-Weight to Overweight. Regency Centers shares fell 1.3% to close at $65.54 on Wednesday. See how other analysts view this stock.
- Wedbush increased the price target for Amazon.com, Inc. (NASDAQ: AMZN) from $180 to $210. Wedbush analyst Scott Devitt maintained an Outperform rating. Amazon shares fell 1.1% to close at $152.12 on Wednesday. See how other analysts view this stock.
- Wells Fargo lowered the price target for argenx SE (NASDAQ: ARGX) from $585 to $470. Wells Fargo analyst Derek Archila maintained an Overweight rating. argenx shares fell 25.1% to close at $338.91 on Wednesday. See how other analysts view this stock.
- Deutsche Bank increased the price target for Micron Technology, Inc. (NASDAQ: MU) from $85 to $90. Deutsche Bank analyst Sidney Ho maintained a Buy rating. Micron shares fell 4.2% to close at $78.69 on Wednesday. See how other analysts view this stock.
- HC Wainwright & Co. boosted the price target for Immunovant, Inc. (NASDAQ: IMVT) from $47 to $51. HC Wainwright & Co. analyst Douglas Tsao maintained a Buy rating. Immunovant shares fell 12.8% to close at $36.18 on Wednesday. See how other analysts view this stock.
- Needham boosted CrowdStrike Holdings, Inc. (NASDAQ: CRWD) price target from $250 to $325. Needham analyst Alex Henderson maintained a Buy rating. CrowdStrike shares fell 1.7% to close at $253.95 on Wednesday. See how other analysts view this stock.
- Morgan Stanley raised Salesforce, Inc. (NYSE: CRM) price target from $290 to $350. Morgan Stanley analyst Keith Weiss upgraded the stock from Equal-Weight to Overweight. Salesforce shares fell 1.6% to close at $260.25 on Wednesday. See how other analysts view this stock.
- Pivotal Research boosted Spotify Technology S.A. (NYSE: SPOT) price target from $170 to $265. Pivotal Research analyst Jeffrey Wlodarczak upgraded the stock from Hold to Buy. Spotify shares fell 1.1% to close at $188.71 on Wednesday. See how other analysts view this stock.
- Baird increased Insulet Corporation (NASDAQ: PODD) price target from $180 to $238. Baird analyst Jeff Johnson upgraded the stock from Neutral to Outperform. Insulet shares fell 3.1% to close at $207.97 on Wednesday. See how other analysts view this stock.
- JP Morgan boosted Glaukos Corporation (NYSE: GKOS) price target from $66 to $91. JP Morgan analyst Allen Gong upgraded the stock from Neutral to Overweight. Glaukos shares fell 2% to close at $79.60 on Wednesday. See how other analysts view this stock.
Check This Out: Micron, Carnival And 3 Stocks To Watch Heading Into Thursday
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.